Evidence map›Paper›PMID 31168733›Full record

ArticleJournal of urban health : bulletin of the New York Academy of Medicine2019

Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.

Alexis M Roth, Alex H Kral, Allison Mitchell, Rohit Mukherjee, Peter Davidson, Stephen E Lankenau

Open access · bronzeAbstract read
In one paragraph

Article in Journal of urban health : bulletin of the New York Academy of Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Community Acceptability of the First State-Authorized Overdose Prevention Center in the United States.Journal of urban health : bulletin of the New York Academy of Medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. No "back to normal" after COVID-19 for our failed drug policies.The International journal on drug policy · 2020
    Article
  14. Article
  15. Expanding a Comprehensive Strategy for Overdose Prevention in the USA.Journal of urban health : bulletin of the New York Academy of Medicine · 2019
    Article
  16. Community Versus Hospital Opioid-Related Overdose Deaths in Illinois.Public health reports (Washington, D.C. : 1974)
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Alexis M RothDepartment of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Room 435, Philadelphia, PA, 19104, USA. alexisroth@drexel.edu.
Alex H KralBehavioral Health Research Division, RTI International, San Francisco, CA, USA.
Allison MitchellDepartment of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Room 435, Philadelphia, PA, 19104, USA.
Rohit MukherjeeDepartment of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Room 435, Philadelphia, PA, 19104, USA.
Peter DavidsonDepartment of Medicine, University of California, San Diego, CA, USA.
Stephen E LankenauDepartment of Community Health and Prevention, Dornsife School of Public Health, Drexel University, 3215 Market Street, Room 435, Philadelphia, PA, 19104, USA.
Drexel University · USRTI International · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overdose prevention sites (OPS) are places where people use previously obtained drugs under the supervision of a health professional. They have been proposed in six United States (US) cities, including Philadelphia, to help reduce opioid-related overdose deaths and public injection. Philadelphia has the highest overdose rate among large cities in the US, which has led a local community-based organization to plan the implementation of OPS. Kensington, a neighborhood with the highest drug mortality overdose rates in the city, is a likely site for the proposed OPS. Given the dearth of research systematically assessing public opinion towards OPS prior to implementation, we enrolled 360 residents and 79 business owners/staff in the Kensington neighborhood in a cross-sectional acceptability study. Face-to-face surveys assessed participant characteristics, experiences with drug-related social problems, and OPS acceptability. Using descriptive statistics, we estimated factors associated with favorability towards opening an OPS in the Kensington neighborhood. Ninety percent of residents were in favor of an OPS opening in Kensington. Support was significantly higher among unstably housed individuals and persons who currently use opioids. In the business sample, 63% of owners/staff were in favor of opening an OPS in Kensington. A greater proportion of Asian/Pacific Islanders, Hispanic/Latinx respondents, and non-Hispanic/Latinx Black respondents were in favor of an OPS opening in Kensington compared with white respondents (p < 0.04). While details about implementation are still being considered, results indicate general acceptability among Kensington residents and businesses for an OPS, especially if it can deliver benefits that curb drug-related social problems. Should an OPS be implemented in Philadelphia, it would be important to monitor changes in drug-related social problems and acceptability post implementation.

Indexed as

AttitudeAdultCross-Sectional StudiesDrug OverdoseFemaleHumansMaleMiddle AgedOpioid-Related DisordersPhiladelphiaRacial GroupsResidence CharacteristicsSocioeconomic FactorsSurveys and QuestionnairesUnited StatesUrban PopulationAcceptabilityOpioidsOverdose prevention sitesSafe consumption sitesSafe injection

Identifiers

PMID31168733
PMCPMC6565835
OpenAlexW2948807784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.